Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-22 | Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the company. |
| 2020-03-20 | Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the company. From 2004 to October 2017, she served in senior management positions at Bristol-Myers Squibb Pharmaceutical Company, most recently serving as president, China, Latin America, Central and Eastern Europe and Middle East. |
| 2021-03-26 | Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the company. |
| 2022-03-25 | Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. |
| 2023-03-24 | Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. Ms. Connaughton received her BA from Johns Hopkins University and her MBA from The Wharton School, University of Pennsylvania. |
| 2024-03-15 | Bernadette Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. |
| 2025-03-18 | Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. |
Data sourced from SEC filings. Last updated: 2026-02-03